Lastly, we assessed the impact of altered RBMS3 expression on LIMS1 mRNA stability in colon cancer cells treated with Actinomycin D, revealing that RBMS3 amplified the stability of LIMS1 mRNA (Figure 4G,H). Here, RBMS3 is linked to colonic neoplasm.